Europe Renal Denervation (RDN) Therapy Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 1.2 Billion by 2030, growing at a CAGR of 12.2% from 2024 to 2030.
The Europe Renal Denervation (RDN) Therapy market is gaining significant traction as an innovative treatment option for managing hypertension and other cardiovascular diseases. RDN therapy is a minimally invasive procedure aimed at disrupting the renal sympathetic nerves, a key player in regulating blood pressure. With growing concerns over hypertension rates in Europe, the demand for RDN therapy is expected to rise substantially in the coming years. This article delves into the types of RDN therapies available and the industries that are driving its requirement.
The two major types of Renal Denervation (RDN) therapy are catheter-based and ultrasound-based systems. Catheter-based RDN therapy involves inserting a catheter into the renal artery, where it delivers radiofrequency energy to disrupt the sympathetic nerves. On the other hand, ultrasound-based RDN uses focused ultrasound waves to treat the renal nerves non-invasively. Both techniques aim to reduce blood pressure, particularly in patients with resistant hypertension who do not respond to conventional treatment.
Industries are becoming increasingly involved in the development and implementation of RDN therapies due to the growing prevalence of hypertension and the increasing awareness of this treatment option. Medical device manufacturers, pharmaceutical companies, and healthcare providers are all playing vital roles in advancing the RDN therapy market. Companies are investing heavily in research and development to improve the efficiency of RDN procedures, making them safer and more effective. This collaboration between industries is expected to contribute to the market's growth.
The healthcare industry, particularly hospitals and clinics specializing in cardiovascular care, is witnessing a rise in demand for RDN therapies. These facilities are adopting the latest advancements in RDN technology to offer patients an alternative treatment option for hypertension. The shift toward non-pharmacological solutions is expected to continue, with more patients opting for RDN therapy as a long-term treatment option.
In conclusion, the Renal Denervation (RDN) Therapy market in Europe is poised for significant growth as both patients and healthcare providers increasingly recognize its potential in managing hypertension. As technology evolves and the therapy becomes more accessible, it is likely to become a primary treatment option for resistant hypertension across the region.
Get an In-Depth Research Analysis of the Europe Renal Denervation (RDN) Therapy Market Size And Forecast [2025-2032]
Medtronic (Covidien)
ReCor
Johnson & Johnson
Boston Scientific
Shanghai Golden Leaf Med Tec Co.
Ltd
Bio-Heart
SyMap Medical
Venus Medtech
Shanghai Microport Ep Medtech Co.
Ltd.
Cryofocus Medtech
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Renal Denervation (RDN) Therapy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Renal Denervation (RDN) Therapy Market
Radiofrequency-based RDN Devices
Cryoablation Devices
Ultrasound-based RDN Devices
Multielectrode RDN Systems
Catheter-based RDN
Surgical RDN
Endovascular RDN
Robotic-assisted RDN
Uncontrolled Hypertension
Resistant Hypertension
Secondary Hypertension
Diabetic Nephropathy
Hospitals
Outpatient Surgery Centers
Specialized Clinics
Research Institutions
Catheter Technologies
Data Integration Technologies
Imaging Technologies
Navigation Technologies
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Renal Denervation (RDN) Therapy Market Research Analysis
1. Introduction of the Europe Renal Denervation (RDN) Therapy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Renal Denervation (RDN) Therapy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Renal Denervation (RDN) Therapy Market, By Type
6. Europe Renal Denervation (RDN) Therapy Market, By Application
7. Europe Renal Denervation (RDN) Therapy Market, By Geography
Europe
Germany
UK
France
8. Europe Renal Denervation (RDN) Therapy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/